H. Kurisu et al., CYTOKINE-MEDIATED ANTITUMOR EFFECT OF BACILLUS-CALMETTE-GUERIN ON TUMOR-CELLS IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 249-253
Intravesical instillation therapy of bacillus Calmette-Guerin (BCG) is
a useful modality for recurrent superficial transitional-cell carcino
ma (TCC) of the urinary bladder. The mechanism of BCG effect has not y
et been well characterized. BCG was tested in vitro for cytokine-media
ted antiproliferative activity against T24 and KK47 cells (cell lines
established from human TCC of the urinary bladder), and ACHN cells (ce
ll line established from human renal cell carcinoma) using a modified
human tumor clonogenic assay. Continuous exposure of cells to BCG at c
oncentrations of more than 5 mu g/ml in the presence of peripheral blo
od mononuclear cells (PBMC) consisting of a mixture of 5 x 10(4) monoc
ytes/dish and 5 x 10(5) lymphocytes/dish, obtained from healthy donors
, significantly inhibited colony formation of T24 and ACHN cells in co
mparison with growth inhibition in the absence of PBMC (P <0.05). Slig
htly inhibited colony formation was observed with KK47 cells under the
same conditions. At the same time various cytokines were measured in
supernatants when BCG and the same conditioned PBMC were co-cultured.
Tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL-1 b
eta) were detected at markedly high levels at 24 h, and interferon gam
ma (IFN gamma) was detected at 120 h. IL-2 and macrophage-colony-stimu
lating factor were not detected. Neutralizing anti-TNF alpha monoclona
l antibody significantly reduced the anti-proliferative activity of AC
HN cells, and anti-IFN gamma antibody reduced that of T24 cells. The r
esults obtained suggest that cytokines mediated by BCG play an importa
nt role in the antitumor activity of BCG and that the sensitivity of b
ladder cancer cells to the cytokines induced by BCG may differ conside
rably.